In a recent study, published in PLOS genetics, a novel form of retinal degeneration in dogs was successfully investigated using whole genome sequencing. The study, led by scientists from the Swedish University of Agricultural Sciences, was enabled by the SciLifeLab National Genomics Infrastructure (NGI) and National Bioinformatics Infrastructure (NBIS).
Stargardt disease (STDG) is an autosomal recessive retinal degeneration disease leading to central vision impairment and blindness. It stems from a mutation in the ABCA4-gene and is the most common inherited retinal disease, affecting 1 in 8-10 thousand children and young adults. The ABCA4-gene encodes for a membrane transporter protein found in the rods and cone photoreceptors of the eye.
So far, there are no effective treatments for Stargardt disease and the only animal model available is a mouse model which works poorly due to big differences between human and mouse eyes.
Earlier studies have shown that dogs are suitable in both finding genetic causes as well as developing new treatments for a number of other retinal degenerative diseases. The current study proposes that the new dog model, which has a “loss of function” mutation in the ABCA4 gene, would make a suitable animal model when studying human STGD.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.